| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.9M | -34.7% |
| Cost of Revenue | $1.4M | -25.6% |
| Gross Profit | $489K | -51.4% |
| R&D Expense | $193K | -18.3% |
| SG&A Expense | $8.1M | -0.3% |
| Operating Income | -$7.9M | +37.7% |
| Pre-tax Income | -$8.8M | +30.2% |
| Income Tax | $0 | — |
| Net Income | -$8.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.9M | +325.0% |
| Accounts Receivable | $1.0M | +45.9% |
| Inventory | $6.4M | -6.1% |
| Current Assets | $17.6M | +46.3% |
| Total Assets | $32.7M | +44.2% |
| Current Liabilities | $11.7M | +562.2% |
| Long-term Debt | $3.4M | +1109.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.5M | +17.4% |
| Capital Expenditures | $430K | +1101.7% |
| Investing Cash Flow | -$4.7M | -304.0% |
| Financing Cash Flow | $9.7M | +2352.3% |
| Free Cash Flow | -$3.9M | +8.1% |
| +30.2% |
| EPS (Basic) | -$0.55 | +34.5% |
| Total Liabilities |
| $11.7M |
| +481.7% |
| Stockholders' Equity | $20.9M | +1.4% |